Abzena (ABZA) Receives New Coverage from Analysts at Peel Hunt

Peel Hunt initiated coverage on shares of Abzena (LON:ABZA) in a research report report published on Thursday. The firm issued a buy rating and a GBX 42 ($0.59) target price on the stock.

A number of other equities analysts have also issued reports on ABZA. FinnCap reiterated a buy rating and issued a GBX 70 ($0.98) target price on shares of Abzena in a research report on Tuesday, November 21st. Numis Securities reiterated a buy rating and issued a GBX 80 ($1.12) target price on shares of Abzena in a research report on Wednesday, December 13th.

Abzena (LON ABZA) opened at GBX 25.52 ($0.36) on Thursday. The stock has a market cap of $54.57 and a PE ratio of -319.00. Abzena has a 12-month low of GBX 25 ($0.35) and a 12-month high of GBX 53 ($0.74).

ILLEGAL ACTIVITY WARNING: This news story was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://sportsperspectives.com/2018/02/11/abzena-abza-receives-new-coverage-from-analysts-at-peel-hunt.html.

About Abzena

Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.

Receive News & Ratings for Abzena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply